GlassScriptPhysician profile
Robert Joseph Liddiard
NPI 1588004865
$1,563.12
in general payments reported to CMS, 2019-2025
28 companies · $37.00 in 2025
The $37.00 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $143 · 2021: $110 · 2022: $495 · 2023: $191 · 2024: $435 · 2025: $37.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $329.26 | 2021-2024 | Fixos, Allopure, Variax |
| Smith+Nephew, INC. | $186.73 | 2019-2025 | Grafix Pl |
| Orthofix Medical, INC. | $117.38 | 2022-2025 | Physio-Stim |
| Nevro Corp. | $98.65 | 2022-2023 | Senza |
| Bioventus LLC | $87.29 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $78.37 | 2019-2025 | Nuzyra |
| Bard Peripheral Vascular, INC. | $73.37 | 2019 | |
| Paragon 28, INC. | $64.10 | 2021-2024 | Ankle Fracture, Mini Monster |
| Kowa Pharmaceuticals America, INC. | $51.74 | 2022-2023 | Seglentis |
| Globus Medical, INC. | $47.10 | 2023 | Ankle Fracture System |
| Abbvie INC. | $43.82 | 2021-2022 | |
| Treace Medical Concepts, INC. | $39.44 | 2022-2024 | |
| Acell, INC. | $38.43 | 2020 | |
| Osiris Therapeutics INC. | $36.01 | 2019 | |
| Resmed Corp | $30.53 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $25.29 | 2022 | |
| Medtronic, INC. | $25.02 | 2023 | Intellis Adaptivestim |
| Medela LLC | $23.59 | 2020 | |
| Boston Scientific Corporation | $21.72 | 2024 | Wavewriter Alpha Prime 16 |
| Next Science LLC | $20.89 | 2022 | |
| Averitas Pharma INC. | $20.56 | 2023 | Qutenza |
| Organogenesis INC. | $19.22 | 2023 | Puraply |
| Biocomposites INC | $17.64 | 2024 | |
| Zimmer Biomet Holdings, INC. | $14.39 | 2022 | |
| Stimwave Technologies Incorporated | $14.16 | 2020 | |
| Integra Lifesciences Corporation | $13.44 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $12.76 | 2019 | |
| Kci USA, INC. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Liddiard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.